Has Alan Nelson received payments from drug or device companies?

Yes. Drug and device makers reported $4,330 in general payments to Alan Nelson across 132 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Alan Nelson did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Alan Nelson come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Alan Nelson

Family Medicine · East Norwich, NYNPI 1841479458

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,365 and has fallen 96.3% since, to $87 in 2024.

$4,330in general payments, 2019–2025

Across 132 payments — averaging $32.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$802
Johnson & Johnson$560
Lilly USA, LLC$482
GSK$437
Boehringer Ingelheim$318
Novo Nordisk$315
plus $1K from 14 others

What the payments were for

Food & beverage$4,24598%
Education$852%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	40	$802
Johnson & Johnson(2 entities)	15	$560
Lilly USA, LLC	13	$482
GSK	6	$437
Boehringer Ingelheim	3	$318
Novo Nordisk	12	$315
Astellas Pharma US Inc	6	$277
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	8	$165
Esperion Therapeutics, Inc.	3	$153
Amgen	2	$146
AbbVie	6	$144
AstraZeneca	2	$139
Novartis	2	$138
Amarin Pharma, Inc.	3	$74
Merck	4	$72
Takeda Pharmaceuticals U.S.A., Inc.	2	$33
Eisai Inc.	2	$30
Medtronic	1	$15
Hikma Pharmaceuticals USA	1	$14
Redhill Biopharma Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,330 in reported general payments places this provider in the 85th percentile of 4,321 family medicine providers in New York.

See all family medicine providers in New York →

Other family medicine in East Norwich

Louis BonavitaEast Syracuse$674K
Martin MahoneyBuffalo$520K
Scott BrehautClinton$514K
David St PeterSaratoga Springs$395K
Matthew PabisNew York$222K
Rajveer SachdevPomona$211K
Eric SchnakenbergHalfmoon$190K
James NorthGlens Falls$186K
Eric BatesNew York$171K
Alexander BlinskiNew York$159K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →